Antifactor Xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin. A pilot study

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2710|41|5|499-502

ISSN： 0269-4727

Source： JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol.41, Iss.5, 2016-10, pp. : 499-502

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retrospective cohort study comparing activated partial thromboplastin time versus anti‐factor Xa activity nomograms for therapeutic unfractionated heparin monitoring in pediatrics

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 5, 2015-05 ,pp. : 788-794

John Wiley & Sons Inc

Access to resources Recommend Favorite

Monitoring Enoxaparin with Antifactor Xa Levels in Obese Patients

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 11, 2015-11 ,pp. : 1007-1015

John Wiley & Sons Inc

Access to resources Recommend Favorite

Further evidence of the limitations of Activated Partial Thromboplastin Time to monitor Argatroban

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 4, 2018-02 ,pp. : 594-597

John Wiley & Sons Inc

Access to resources Recommend Favorite

Influence of Fibrinogen Degradation Products on Thrombin Time, Activated Partial Thromboplastin Time and Prothrombin Time of Canine Plasma

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 3, 2000-09 ,pp. : 123-130

Karger

Access to resources Recommend Favorite

Multiple Intracranial Hemorrhages at the Time of a Transiently Prolonged Activated Partial Thromboplastin Time in an Infant with Congenital Factor VII Deficiency

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 1, 1999-01 ,pp. : 14-16

Karger

Access to resources Recommend Favorite